MetLife Investment Management’s Protagonist Therapeutics PTGX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.35M	Sell	31,799 -641	-2%	-$56.8K	0.02%	795
2025 Q4	$2.83M	Sell	32,440 -1,406	-4%	-$115K	0.01%	898
2025 Q3	$2.25M	Sell	33,846 -924	-3%	-$52.5K	0.01%	1029
2025 Q2	$1.92M	Sell	34,770 -20	-0.1%	-$960	0.01%	1012
2025 Q1	$1.68M	Sell	34,790 -1,008	-3%	-$42.2K	0.01%	1123
2024 Q4	$1.38M	Buy	35,798 +1,993	+6%	+$86.9K	0.01%	1255
2024 Q3	$1.52M	Hold	33,805	–	–	0.01%	1165
2024 Q2	$1.17M	Buy	33,805 +5,209	+18%	+$153K	0.01%	1262
2024 Q1	$827K	Hold	28,596	–	–	0.01%	1405
2023 Q4	$656K	Hold	28,596	–	–	﹤0.01%	1528
2023 Q3	$477K	Hold	28,596	–	–	﹤0.01%	1668
2023 Q2	$790K	Buy	28,596 +4,682	+20%	+$117K	0.01%	1402
2023 Q1	$550K	Hold	23,914	–	–	﹤0.01%	1582
2022 Q4	$261K	Hold	23,914	–	–	﹤0.01%	2080
2022 Q3	$202K	Hold	23,914	–	–	﹤0.01%	2298
2022 Q2	$189K	Hold	23,914	–	–	﹤0.01%	2363
2022 Q1	$566K	Buy	23,914 +8,826	+58%	+$249K	﹤0.01%	1696
2021 Q4	$516K	Hold	15,088	–	–	﹤0.01%	1489
2021 Q3	$267K	Hold	15,088	–	–	﹤0.01%	1900
2021 Q2	$677K	Buy	15,088 +1,564	+12%	+$51.6K	0.01%	1396
2021 Q1	$350K	Hold	13,524	–	–	﹤0.01%	1725
2020 Q4	$273K	Hold	13,524	–	–	﹤0.01%	1819
2020 Q3	$264K	Buy	13,524 +2,728	+25%	+$51.2K	﹤0.01%	1690
2020 Q2	$191K	Buy	+10,796	New	+$135K	﹤0.01%	1938
2019 Q4	–	Sell	-9,114	Closed	-$109K	–	2319
2019 Q3	$109K	Buy	+9,114	New	+$115K	﹤0.01%	2285